The findings showed a slight trend toward faster improvement in skin symptoms, particularly rashes, among individuals receiving early RTX, although the effect did not reach statistical significance.
← all excerpts
Immunobiologics in juvenile dermatomyositis: a systematic review of promising therapeutic advances.
1
—
—